Truncation
Truncation — The premature termination of a peptide chain during synthesis, producing a shorter-than-intended sequence as a synthesis impurity.
What Is Truncation?
Truncation is the systematic removal of amino acid residues from the N-terminus or C-terminus of a peptide to identify the minimum active sequence. Truncation studies are a fundamental SAR tool that defines the pharmacophore (minimum sequence required for biological activity) and enables optimization of shorter, more drug-like analogs.
Truncation Examples
- CGRP: Full 37-mer progressively truncated; CGRP(8-37) retains antagonist activity
- Neurotensin: NT(8-13) hexapeptide retains full agonist activity of the 13-mer
- Alpha-MSH to KPV: The 13-residue alpha-MSH truncated to the C-terminal tripeptide retains anti-inflammatory activity
- Galanin: Galanin(1-15) retains full biological activity despite losing 14-15 residues
Frequently Asked Questions
What is Truncation?
The premature termination of a peptide chain during synthesis, producing a shorter-than-intended sequence as a synthesis impurity.
Why is Truncation important in peptide research?
Truncation is a fundamental concept in synthesis as it relates to peptide science. It directly influences experimental design, compound characterization, and the reliability of research outcomes across biochemistry and molecular biology disciplines.